FST-100 in the Treatment of Acute Viral Conjunctivitis
FST-100 in the Treatment of Acute Viral Conjunctivitis
This randomized, double masked, multi-center study is being conducted to support the safety
 and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to
 show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution
 of acute viral conjunctivitis.
Inclusion Criteria:

 -  Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye

 Exclusion Criteria:

 -  Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle